Bloomage BioTechnology
Beijing · Founded 1998
About Bloomage BioTechnology
Bloomage BioTechnology (the “Company”, collectively referred to as the “Group” together with its subsidiaries), founded on 3rd April, 2006 in the Cayman Islands, is an International Group dedicated to develop in the field of biomedicine. Its core subsidiary is a manufacturer and distributor of sodium hyaluronic acid (referred to as “HA”) and focuses mainly on the development, manufacture and sale of various HA raw materials and end products. The Group has been listed on the Main Board of the Stock Exchange of Hong Kong with the stock code 00963.
Company Facts
- Founded: 1998
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $500K – $1M
- Total funding: $95.3M
- Funding stage: IPO
- Last round: Post-IPO Debt (Sep 2023)
- Ticker: sse:688363
- Website: bloomagebio-tech.comeindex.php
- Phone: +86 10 85670099
Industries & Categories
Biotechnology, Chemical, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/bloomage-biotechnology-123189 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.